fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Updated on July 15, 2019

Stock/Share Code - TORNTPHARM

Torrent Pharmaceuticals is engaged in one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.

Below is the details of TORNTPHARM Torrent Pharmaceuticals Ltd

Market Cap₹26,480 Cr.
Current Price ₹1,515.45 as on 19 Jul 19
52 Week High / Low Price₹1,964 / ₹1,329.6
Face Value₹5
Stock P/E35.54
Book Value₹296.36
Dividend Yield0.89 %
ROCE9.28 %
ROE9.78 %
Sales Growth (3yrs)6.83 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is expected to give good quarter Company has a good return on equity (ROE) track record: 3 Years ROE 24.95% Company has been maintaining a healthy dividend payout of 36.96%
Cons: The company has delivered a poor growth of 8.91% over past five years.

Torrent Pharmaceuticals Ltd Price Chart

Torrent Pharmaceuticals Ltd Price Chart

Torrent Pharmaceuticals Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹151.2 26.06 ₹98,336.74 Cr. 0.49 ₹635.88 Cr. -52.63 2.68 7163.92 10.41
2. Cipla ₹536.7 29.66 ₹45,028.9 Cr. 0.54 ₹357.68 Cr. 57.90 19.09 4403.98 9.64
3. Dr Reddy's Labs ₹2,613.15 22.81 ₹44,478.27 Cr. 0.75 ₹455.4 Cr. 67.36 13.39 4029.60 7.75
4. Piramal Enterp. ₹1,903.95 25.32 ₹44,159.07 Cr. 1.02 ₹456.86 Cr. -88.42 23.02 3679.67 8.85
5. Aurobindo Pharma ₹552.4 16.21 ₹39,396.97 Cr. 0.37 ₹585.38 Cr. 15.67 30.70 5292.20 22.85
6. Biocon ₹240.3 43.80 ₹32,514 Cr. 0.18 ₹213.7 Cr. 63.88 30.72 1528.80 8.41
7. Torrent Pharma. ₹17.25 35.54 ₹26,480.39 Cr. 0.89 ₹164 Cr. -25.45 1.88 1357.00 9.28
8. Torrent Pharma. ₹17.25 36.27 ₹26,480.39 Cr. 0.89 -₹152 Cr. -37.72 8.67 1856.00 13.23

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Torrent Pharmaceuticals Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019
Sales1,3241,0581,2499628471,0251,0401,3321,4521,4721,4811,357
YOY Sales Growth %-29.08%-32.44%23.05%-2.83%-36.03%-3.12%-16.73%38.46%71.43%43.61%42.4%1.88%
Expenses8578149438527267897811,0401,0401,0161,0301,063
Material Cost %28.1%29.96%29.94%33.68%26.09%27.32%23.75%27.63%27.41%25.61%24.58%29.92%
Employee Cost %13.52%17.49%13.05%17.88%22.08%20.2%19.33%17.34%17.36%16.78%17.49%18.87%
Operating Profit467244306110121236259292412456451294
OPM %35%23%24%11%14%23%25%22%28%31%30%22%
Other Income4959711201099181513410813227
Interest48514657555171117117120125119
Depreciation61646876747889143141144147147
Profit before tax4071882639710119818083188300192255
Tax %17%10%11%-18%17%20%89%-165%35%8%5%36%
Net Profit3371692341148415820220122277182164
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales8819841,1651,4191,7502,0712,7603,3583,4685,4394,5514,2285,762
Sales Growth %28.47%11.72%18.44%21.77%23.32%18.31%33.3%21.68%3.26%56.86%-16.33%-7.1%%
Expenses7207839361,0401,3541,6802,0842,2982,6242,9913,4243,3214,149
Material Cost %35.59%36.2%36.02%33.05%34.33%38.94%35.49%29.78%31.24%21.74%30.46%26.39%%
Manufacturing Cost %5.68%5.13%5.46%5.26%6.36%5.79%5.61%5.94%6.6%4.11%5.44%6.25%%
Employee Cost %12.02%11.23%10.89%11%15.54%14.93%13.27%12.47%14.63%10.52%15.36%19.54%%
Other Cost %28.59%27.12%28.12%24.26%21.23%21.75%21.38%20.42%23.43%18.62%23.97%26.37%%
Operating Profit1602012293793963916761,0618432,4481,1279071,613
OPM %18%20%20%27%23%19%24%32%24%45%25%21%28%
Other Income1419381859849836306293300332382
Interest2021382939403758173180202294481
Depreciation3033375458647279180213269384579
Profit before tax1241661913143583716659587962,348955562935
Tax %9%6%2%34%19%16%18%20%22%26%11%14%
Net Profit1131561872072913115467626231,743854482745
EPS in Rs6.468.8910.7011.7616.5417.7030.3543.3534.5794.5950.4728.48
Dividend Payout %22%19%18%24%23%23%36%22%31%34%28%49%

Compounded Sales Growth

  • 10 Years:: 15.70%
  • 5 Years:: 8.91%
  • 3 Years:: 6.83%
  • TTM:: 35.77%

Compounded Profit Growth

  • 10 Years:: 11.09%
  • 5 Years:: -5.14%
  • 3 Years:: -10.40%
  • TTM:: 54.56%

Return on Equity

  • 10 Years:: 27.80%
  • 5 Years:: 26.52%
  • 3 Years:: 24.95%
  • Last Year:: 9.78%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital42424242424242858585858585
Equity Capital42.3142.3142.3142.3142.3142.3142.3184.6284.6284.6284.6284.6284.62
Reserves4225436908391,0511,2621,6092,2052,6213,6234,3694,4724,930
Borrowings2793424825225725796931,1322,5212,2492,4465,8454,467
Other Liabilities2263164114585717091,0329381,3021,4501,1521,4192,545
Trade Payables133.95163.83218.06261.66298.95373.4471.86517.9662.72739.29624.76816.98582
Total Liabilities9701,2431,6251,8612,2362,5923,3764,3606,5297,4068,05111,82012,027
Fixed Assets4034484875265886367918362,7642,6813,5237,4297,452
Gross Block543.31612.3680.79771.79884.93987.11203.881321.293416.053531.564634.198905.1
Accumulated Depreciation140.19164.78193.56246.16297.32350.8412.5485.13652.55850.171110.71476.57
CWIP4079461054427276508628984473447471
Investments95158245231431478190322434918936625486
Other Assets4325598489981,1731,4512,1182,6942,7042,8233,1193,3193,618
Inventories185.88166.53191.84227.88342.83393.13697.09694.51781.15970.131032.291299.41358
Trade receivables165.61198.48240.81259.78340.01409.61831.271317.431181.32911.51018.471108.041356
Cash Equivalents10.2597.67183.31346.79265.33366.68277.76218.4969.6882.3778.2257.12238
Loans n Advances70.0895.84231.57164.05141.49181.94234.44296.38435.15527.45629.17700.1884
Total Assets9701,2431,6251,8612,2362,5923,3764,3606,5297,4068,05111,82012,027

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity91227202307233396-693101,0652,403676
Profit from operations169.51222.78262.22412.98425.37423.18769.351089.961112.682829.021410.75
Working Capital Changes-61.4924.62-42.8-44.1-123.3648.19-734.84-562.87-13.7463.75-479.84
Taxes paid-17.04-20.44-17.92-62.01-68.71-75-103.2-217.01-33.78-489.77-255.18
Cash from Investing Activity-104-139-31-137-242-142-89-326-2,099-584-527
Fixed Assets Purchased-91.63-121.15-50.94-150.21-241.17-83.29-294.63-364.45-176.13-466.82-471.78
Fixed Assets Sold1.943.120.851.061.91.151.281.815.796.970.59
Investments purchased0-19.0200-0.95-17.5200000
Investments sold0.030.113.238.897.8711.368.6910.5415.92103.3672.83
Cash from Financing Activity-38350-4-69-1922586996-1,326-130
Proceeds from Borrowings36.6754.5120.31128.790.1138.3242.53426.741660.394901368.61
Repayment of Borrowings00-60.93-66.99-71.54-163.33-103.2-12.7-273.19-774.16-1129.87
Interest Paid-21.56-19.35-26.02-25.97-28.17-30.6-30.71-60.83-192.42-201.96-187.87
Dividends Paid-53.17-0.11-33.19-41.01-59.12-137.34-83.44-267.39-199.69-839.7-203.67
Net Cash Flow-51123171165-7862-13370-3849319

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %21%22%22%28%25%26%35%35%22%44%17%9%
Debtor Days697475677172110143124618296
Inventory Turnover5.045.586.506.766.135.635.064.834.706.214.553.63

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Torrent Pharmaceuticals Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.